24 Jul 2026 Jennifer Doudna’s Scribe Therapeutics Rockets at IPO Shares of Scribe Therapeutics, a genetic-medicines company co-founded by Nobel laureate Jennifer Doudna, shot up on their first day of trading Friday, continuing a rebound for biotech IPOs this year. Scribe sold ...
